Solstice Biologics Garners $18,000,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7daf7f46-5fc2-4b00-bdf3-0426ef9354a6&Preview=1 -
Date
1/5/2013 -
Company Name
Solstice Biologics -
Mailing Address
1700 Owens Street San Francisco, CA 94158 -
Company Description
Solstice Biologics is a private company focused on solving the problem of targeting and delivery of nucleic acid therapeutics. The company is developing small, cell-permeable RNAi pro-drugs that can enter many different cell types and deliver on the promise of RNAi therapeutics. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$18,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
venBio -
Venture Investor
Aeris Capital AG
